ONCOSIGNATURE - Trademark Details
Status: 700 - Registered
Serial Number
79223972
Registration Number
5718472
Word Mark
ONCOSIGNATURE
Status
700 - Registered
Status Date
2019-04-09
Filing Date
2017-09-22
Registration Number
5718472
Registration Date
2019-04-09
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260109, 260116, 260117, 260121, 260131 - Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle. Circles touching or intersecting. Two concentric circles. Circles that are totally or partially shaded. Five or more circles.
Published for Opposition Date
2019-01-22
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
CORWIN, CHARLOTTE K
Statements
Indication of Colors claimed
The color(s) orange and blue is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized wording "ONCOSIGNATURE" with "ONCO" in orange and "SIGNATURE" in blue. Above the wording are two interlocked circles, each consisting of an outer border of small blue circles and an inner layer of larger orange circles.
Goods and Services
Pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; medical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; veterinary pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; pharmaceutical and medical preparations for treatment, prevention and alleviation of cancer; pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; biological preparations for medical and veterinary purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; chemical preparations for therapeutic use, namely, for pharmaceutical or medical purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy prediction and/or analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits and does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes
Goods and Services
Scientific and technological research and consultation services, namely, in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, drug repurposing, and identification of rational drug combinations; industrial analysis and research services, namely, industrial research in the field of oncology; basic medical research and medical clinical research, hereunder for development of therapeutics; drug discovery services; consultancy in the field of pharmaceutical research and development; medical and scientific research related to cancer and cancer therapy, including research related to treatment, prevention and alleviation of cancer; pharmaceutical research services related to prediction of drug treatment efficacy; medical research services related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction; medical research, namely, analysis related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-02
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-01-02
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Julie A. Greenberg
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1382289
International Registration Date
2017-09-22
International Publication Date
2017-12-28
International Renewal Date
2027-09-22
Auto Protection Date
2019-06-28
International Status
001 - Request for extension of protection established
International Status Date
2017-12-28
Priority Claimed In
True
Priority Claimed Date
2017-03-24
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2017-12-28 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2018-01-02 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-01-02 | ASSIGNED TO EXAMINER |
| 2018-01-05 | NON-FINAL ACTION WRITTEN |
| 2018-01-06 | APPLICATION FILING RECEIPT MAILED |
| 2018-01-06 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2018-01-18 | REFUSAL PROCESSED BY MPU |
| 2018-01-18 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2018-02-03 | REFUSAL PROCESSED BY IB |
| 2018-07-18 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2018-08-02 | ASSIGNED TO LIE |
| 2018-08-03 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-08-03 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-08-27 | ASSIGNED TO EXAMINER |
| 2018-12-13 | EXAMINERS AMENDMENT -WRITTEN |
| 2018-12-13 | EXAMINERS AMENDMENT E-MAILED |
| 2018-12-13 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2018-12-13 | EXAMINER'S AMENDMENT ENTERED |
| 2018-12-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-01-02 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-01-09 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2019-01-09 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2019-01-22 | PUBLISHED FOR OPPOSITION |
| 2019-01-22 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-01-25 | NOTIFICATION PROCESSED BY IB |
| 2019-01-25 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2019-01-25 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2019-04-09 | REGISTERED-PRINCIPAL REGISTER |
| 2019-07-09 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2019-07-31 | FINAL DISPOSITION PROCESSED |
| 2019-07-31 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2019-08-16 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2021-07-13 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-07-13 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-07-13 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-07-13 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 2021-07-13 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-07-13 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
